Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:17 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | VANGUARD GROUP INC | 5,471,930 6.81% | 1,659,906 (+43.54%) | View |
| 2024-01-29 5:25 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | BlackRock Inc. BLK | 4,435,481 5.6% | 841,407 (+23.41%) | View |
| 2024-01-29 4:00 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | ARK Investment Management LLC | 7,025,116 8.74% | 2,659,286 (+60.91%) | View |
| 2024-01-23 10:13 am Sale | 13G | VERVE THERAPEUTICS INC VERV | STATE STREET CORP STT | 3,866,764 4.81% | -604,285 (-13.52%) | View |
| 2023-12-11 4:16 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | GV 2017 L.P. | 12,349,086 15.4% | 1,800,000 (+17.06%) | View |
| 2023-12-11 09:09 am Sale | 13G | VERVE THERAPEUTICS INC VERV | FMR LLC | 3,803,214 4.842% | -3,102,208 (-44.92%) | View |
| 2023-02-14 10:40 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | SINGER JAMES R | 5,000,000 8.1% | 2,535,000 (+102.84%) | View |
| 2023-02-13 9:27 pm Sale | 13G | VERVE THERAPEUTICS INC VERV | Casdin Capital LLC | 2,290,571 3.7% | -847,596 (-27.01%) | View |
| 2023-02-13 4:08 pm Sale | 13G | VERVE THERAPEUTICS INC VERV | ARCH Venture Fund X L.P. | 0 0% | -2,508,809 (Position Closed) | View |
| 2023-02-10 4:05 pm Sale | 13G | VERVE THERAPEUTICS INC VERV | GV 2017 L.P. | 10,549,086 17.1% | -424,925 (-3.87%) | View |
| 2023-02-10 2:56 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | BlackRock Inc. BLK | 3,594,074 5.8% | 3,594,074 (New Position) | View |
| 2023-02-10 2:33 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | ARK Investment Management LLC | 4,365,830 7.09% | 4,365,830 (New Position) | View |
| 2023-02-09 12:39 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | FMR LLC | 6,905,422 11.209% | 511,609 (+8.00%) | View |
| 2023-02-09 11:35 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | VANGUARD GROUP INC | 3,812,024 6.19% | 3,812,024 (New Position) | View |
| 2023-02-07 1:11 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | STATE STREET CORP STT | 4,471,049 7.26% | 4,471,049 (New Position) | View |
| 2023-02-06 2:58 pm Sale | 13G | VERVE THERAPEUTICS INC VERV | WELLINGTON MANAGEMENT GROUP LLP | 859,102 1.39% | -3,080,406 (-78.19%) | View |
| 2022-08-10 08:10 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | FMR LLC | 6,393,813 10.976% | 1,392,331 (+27.84%) | View |
| 2022-02-14 5:15 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | GV 2017 L.P. | 10,974,011 22.78% | 10,974,011 (New Position) | View |
| 2022-02-14 09:27 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | Casdin Capital LLC | 3,138,167 6.5% | 100,000 (+3.29%) | View |
| 2022-02-09 1:26 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | ARCH Venture Fund X L.P. | 2,508,809 5.2% | 2,508,809 (New Position) | View |